Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Choosing sectors for retirement requires matching income needs with risk tolerance. This guide highlights practical picks to support steady retirement cash flow.
23,834 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
When a tech chief sells shares, investors take notice. This deep-dive explains what InterDigital's CTO's sale could m...
Market mood slides while retail spend stays resilient. Three beaten-down consumer stocks july look poised for catalys...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
A surge in triple-leveraged ETFs has driven notional exposure to about $500 billion, intensifying daily volatility an...
Starlink’s rumored mobile service could shake up how Americans connect on the go. This guide breaks down what that me...
Chinese memory-maker CXMT gears up for a high-profile $8.6 billion IPO, sparking renewed pressure on U.S. and Asian m...
Amazon executed a $25 billion debt sale that drew heavy demand and extended its growth funding runway. Here are three...
Imagine a Corcept director with 1.5 million shares weathering a 50% stock crash and a strong rebound. This article br...
Bitcoin whales boosted holdings by 200,000 BTC in the last 30 days, yet price momentum cooled as underwater traders c...
In February 2026, a disciplined $1,000 starter plan can still unlock meaningful exposure to AI-driven growth. This re...
Powell Industries stock soars after a significant stake increase by a prominent fund, driving a 161% annual gain. Thi...